跳至主要内容
临床试验/ACTRN12611000595910
ACTRN12611000595910已完成不适用

A primary care study of skin lesions excisions from the lower limb and groin and excisions from any site in diabetics comparing the effect of a 2g oral dose of cephalexin administered 30-60 minutes prior to the operation and a placebo in the prevention of subsequent surgical site infection

James Cook University0 个研究点目标入组 100 人开始时间: 2011年6月9日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • 1. >18 yrs old
  • 2. Capable of informed consent
  • 3. Presenting for excision of a minor skin lesion from lower leg or groin OR Diabetic presenting for skin lesion excision from any site

排除标准

  • Currently taking antibiotics or clinically indicated for antibiotic treatment following excision
  • Repair of lacerations or lesion considered contaminated/infected prior to surgery
  • Excision not requiring sutures (E.g. shave biopsy or curette)
  • Excision of sebaceous cyst
  • Patient unable to return for suture removal
  • Penicillin or cephalosporin allergy

研究者

相似试验